유전자 편집 시장 : 용도별, 기술별, 장소별, 업계별, 제품별 - 경영진 및 컨설턴트 가이드 포함(2025-2029년)

Gene Editing Markets. By Application, Technology, Place, Industry & Product with Executive and Consultant Guides. 2025 to 2029

US $ 6,995 ￦ 9,926,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,893,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,860,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유전자 편집은 점점 더 강력해지고 있습니다. CRISPR 및 이와 유사한 도구는 생명공학의 모든 분야에서 새로운 용도를 찾고 있으며, CRISPR은 살아있는 인간 세포의 유전자를 수정하여 의료 분야에 적용하기 시작했습니다. 불치병은 이미 치료되고 있습니다. 더 많은 질병이 진행 중입니다. 급성장 노선이 가속화되고 여러 산업에서 새로운 용도가 개발되고 있습니다. 기술이 비약적으로 발전할 때마다 새로운 기회가 생겨나고 있습니다.

세계의 유전자 편집 시장에 대해 조사했으며, 시장 개요와 함께 용도별, 기술별, 유형별, 산업별, 제품별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 가이드

제2장 소개와 시장 정의

• 조사 방법
• 유전자 편집이란 무엇인가?
• CRISPR 사례
• 염색체, 유전자, 후생유전학
• 시장 정의
• 관점 : 헬스케어비 지출

제3장 시장 구조

• 시장 구조 치료제
  • 연구개발(R&D) 기업
  • 바이오테크놀러지 기업
  • 제네릭 의약품 제조업체
  • 대형 제약회사
  • CRO
  • CMO
  • 전문의약품 회사
  • 의약품 판매업체
  • 소매 약국
  • 도매업체
  • 온라인 약국
  • 의료 기술 기업
  • 약제 급여 관리자(PBM)
  • 임상 검사실
  • 의료기기 제조업체
  • 규제기관
• 시장 구조 진단
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품·시약 제조업체
  • 병리 공급업체
  • 독립계 임상 검사실
  • 공공 국립/지역 연구소
  • 병원 검사실
  • 임상 검사실
  • 감사 기관
  • 인증 기관

제4장 시장 동향

• 성장 촉진요인
• 성장 저해요인

제5장 유전자 편집의 최근 동향

제6장 주요 기업

• 10x Genomics, Inc.
• 4D Molecular Therapeutics
• Abeona Therapeutics
• Acrigen Biosciences
• Adarx Pharmaceuticals
• Adverum Biotechnologies
• Affini-T Therapeutics
• Agilent
• Arbor Biotechnologies
• Arcturus Therapeutics
• Axxam
• Beam Therapeutics
• Beckman Coulter Diagnostics(Danaher)
• Becton, Dickinson and Company
• Binx Health
• bioMerieux Diagnostics
• Bio-Rad Laboratories, Inc.
• Bluebird Bio
• Caribou Biosciences
• Cell Microsystems
• Cellenion(BICO)
• Century Therapeutics
• Chroma Medicine
• Creative Biogene
• Crispr Therapeutics
• Editas Medicine
• ERS Genomics
• FASMAC
• Genscript Biotech
• Illumina
• Inscripta
• Intellia Therapeutics
• J&J Innovative Medicine
• Locus Biosciences
• Mammoth Biosciences
• Metagenomi
• Myllia Biotechnology
• Namocell
• NRGene
• Poseida Therapeutics
• Precision Biosciences
• Prime Medicine
• Proof Diagnostics
• Regeneron Pharmaceuticals
• Revvity
• Roche Diagnostics
• Sherlock Biosciences
• Thermo Fisher Scientific
• Twist Bioscience
• Verve Therapeutics
• Vivlion
• Wave Life Science

제7장 세계의 유전자 편집 시장

• 국가별 세계 시장 개요
• 용도별 세계 시장 - 개요
• 기술별 세계 시장 - 개요
• 유형별 세계 시장 - 개요
• 업계별 세계 시장 - 개요
• 제품별 세계 시장 - 개요

제8장 세계의 유전자 편집 시장 - 용도별

• 세포주
• 식물
• 동물
• 세포 치료
• 유전자 치료
• 진단
• 연구
• 기타

제9장 세계의 유전자 편집 시장 - 기술별

• CRISPR
• TALEN
• ZFN
• 메가뉴클레아제
• 기타

제10장 세계의 유전자 편집 시장 - 장소별

• 생체내
• 생체외
• 체외

제11장 세계의 유전자 편집 시장 - 업계별

• 제약
• 임상
• 학술
• 수탁
• 기타

제12장 세계의 유전자 편집 시장 - 제품별

• 기기
• 세포
• 시약
• 기타

제13장 부록

ksm

영문 목차

영문목차

OVERVIEW:

Gene Editing is moving from strength to strength. CRISPR and similar tools are finding new uses in every area of biotechnology. It started with Medical applications by changing genes in living human cells. Uncurable diseases have already being cured. More are on the way. A fast growth path is accelerating. New applications are developing in multiple industries. New opportunities are arising with every technological breakthrough. Understand the various opportunities. Find out what is expected in the near term and the long term. Get a handle on realistic growth expectations. Our research makes you the expert in your organization.

All report data is available in Excel format on request.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. Methodology
  • 2.1.1. Methodology
  • 2.1.2. Sources
  • 2.1.3. Authors
• 2.2. What is Gene Editing?
• 2.3. The CRISPR Example
  • 2.3.1. What is CRISPR?
  • 2.3.2. The CRISPR Family
• 2.4. Chromosomes, Genes and Epigenetics
  • 2.4.1. Chromosomes
  • 2.4.2. Genes
  • 2.4.3. Epigenetics
• 2.5. Market Definition
  • 2.5.1. Revenue Market Size
• 2.6. Perspective: Healthcare Spending
  • 2.6.1. Global Healthcare Spending
  • 2.6.2. Spending on Healthcare and Pharmaceuticals
  • 2.6.3. Spending on Diagnostics
  • 2.6.4. Important Role of Insurance for Medical Services

3. Market Structure

• 3.1. Market Structure Therapeutics
  • 3.1.1. Research and Development (R&D) Companies
  • 3.1.2. Biotechnology Companies
  • 3.1.3. Generic Drug Manufacturers
  • 3.1.4. Big Pharmaceuticals
  • 3.1.5. Contract Research Organizations (CROs)
  • 3.1.6. Contract Manufacturing Organizations (CMOs)
  • 3.1.7. Specialty Pharmaceutical Companies
  • 3.1.8. Pharmaceutical Distributors
  • 3.1.9. Retail Pharmacies
  • 3.1.10. Wholesalers
  • 3.1.11. Online Pharmacies
  • 3.1.12. Health Technology Companies
  • 3.1.13. Pharmacy Benefit Managers (PBMs)
  • 3.1.14. Clinical Laboratories
  • 3.1.15. Medical Device Companies
  • 3.1.16. Regulatory Bodies
• 3.2. Market Structure Diagnostics
  • 3.2.1. Academic Research Lab
  • 3.2.2. Diagnostic Test Developer
  • 3.2.3. Instrumentation Supplier
  • 3.2.4. Chemical/Reagent Supplier
  • 3.2.5. Pathology Supplier
  • 3.2.6. Independent Clinical Laboratory
  • 3.2.7. Public National/regional Laboratory
  • 3.2.8. Hospital Laboratory
  • 3.2.9. Physicians Office Lab (POLS)
  • 3.2.10. Audit Body
  • 3.2.11. Certification Body

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. Cell Therapy
  • 4.1.2. Gene Therapy
  • 4.1.3. The New Agriculture
  • 4.1.4. Genetics and Cell Metabolism
• 4.2. Factors Limiting Growth
  • 4.2.1. The Cost Curve
  • 4.2.2. Time and Trials
  • 4.2.3. The Price Barrier

5. Recent Developments in Gene Editing

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. CRISPR tool allows for remote-controlled gene-editing
• 5.3. CRISPR Making Sweeter Tomatoes
• 5.4. Researchers Create gene-edited prawns
• 5.5. Gene Editing Corrects Cystic Fibrosis
• 5.6. CRISPR gene editing to change healthcare?
• 5.7. CrisprBits Collaborates With MolBio Diagnostics
• 5.8. Sherlock Bioscience to Launch Free AI-Based Operating System
• 5.9. Sherlock Biosciences to Acquire Sense Biodetection
• 5.10. CRISPR Enzyme Discovery Opens New Applications
• 5.11. Sherlock Biosciences Adds Ambient Amplification to Toolkit
• 5.12. Rice University Adapts CRISPR Enzyme
• 5.13. Princeton Group Develops Cas13 Assay for Point-of-Care Use
• 5.14. Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
• 5.15. Sherlock Biosciences Raises $80M
• 5.16. Broad Institute Considers CRISPR Respiratory Panels to Replace PCR
• 5.17. Medix Biochemica Acquires MyPols Biotec
• 5.18. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA
• 5.19. Genome Diagnostics Makes Euro-1M Investment in Scope Biosciences
• 5.20. CRISPR Test Could be used for Asymptomatic Screening
• 5.21. Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
• 5.22. Pandemic Accelerates Development of CRISPR Diagnostics
• 5.23. ERS Genomics Licenses CRISPR Patents to Vivlion
• 5.24. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test
• 5.25. ERS Genomics, FASMAC to Commercialize CRISPR-Cas9
• 5.26. The Nobel Prize in Chemistry 2020 - CRISPR Wins

6. Key Companies

• 6.1 10x Genomics, Inc.
• 6.2 4D Molecular Therapeutics
• 6.3. Abeona Therapeutics
• 6.4. Acrigen Biosciences
• 6.5. Adarx Pharmaceuticals
• 6.6. Adverum Biotechnologies
• 6.7. Affini-T Therapeutics
• 6.8. Agilent
• 6.9. Arbor Biotechnologies
• 6.10. Arcturus Therapeutics
• 6.11. Axxam
• 6.12. Beam Therapeutics
• 6.13. Beckman Coulter Diagnostics (Danaher)
• 6.14. Becton, Dickinson and Company
• 6.15. Binx Health
• 6.16. bioMerieux Diagnostics
• 6.17. Bio-Rad Laboratories, Inc.
• 6.18. Bluebird Bio
• 6.19. Caribou Biosciences
• 6.20. Cell Microsystems
• 6.21. Cellenion (BICO)
• 6.22. Century Therapeutics
• 6.23. Chroma Medicine
• 6.24. Creative Biogene
• 6.25. Crispr Therapeutics
• 6.26. Editas Medicine
• 6.27. ERS Genomics
• 6.28. FASMAC
• 6.29. Genscript Biotech
• 6.30. Illumina
• 6.31. Inscripta
• 6.32. Intellia Therapeutics
• 6.33. J&J Innovative Medicine
• 6.34. Locus Biosciences
• 6.35. Mammoth Biosciences
• 6.36. Metagenomi
• 6.37. Myllia Biotechnology
• 6.38. Namocell
• 6.39. NRGene
• 6.40. Poseida Therapeutics
• 6.41. Precision Biosciences
• 6.42. Prime Medicine
• 6.43. Proof Diagnostics
• 6.44. Regeneron Pharmaceuticals
• 6.45. Revvity
• 6.46. Roche Diagnostics
• 6.47. Sherlock Biosciences
• 6.48. Thermo Fisher Scientific
• 6.49. Twist Bioscience
• 6.50. Verve Therapeutics
• 6.51. Vivlion
• 6.52. Wave Life Science

7. The Global Market for Gene Editing

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market by Application - Overview
  • 7.2.1. Table - Global Market by Application
  • 7.2.2. Chart - Global Market by Application - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Application - Base Year
  • 7.2.4. Chart - Global Market by Application - Final Year
  • 7.2.5. Chart - Global Market by Application - Share by Year
  • 7.2.6. Chart - Global Market by Application - Segment Growth
• 7.3. Global Market Technology - Overview
  • 7.3.1. Table - Global Market by Technology
  • 7.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market by Technology - Base Year
  • 7.3.4. Chart - Global Market by Technology - Final Year
  • 7.3.5. Chart - Global Market by Technology - Share by Year
  • 7.3.6. Chart - Global Market by Technology - Segment Growth
• 7.4. Global Market Type - Overview
  • 7.4.1. Table - Global Market by Type
  • 7.4.2. Chart - Global Market by Type - Base/Final Year Comparison
  • 7.4.3. Chart - Global Market by Type - Base Year
  • 7.4.4. Chart - Global Market by Type - Final Year
  • 7.4.5. Chart - Global Market by Type - Share by Year
  • 7.4.6. Chart - Global Market by Type - Segment Growth
• 7.5. Global Market Industry - Overview
  • 7.5.1. Table - Global Market by Industry
  • 7.5.2. Chart - Global Market by Industry - Base/Final Year Comparison
  • 7.5.3. Chart - Global Market by Industry - Base Year
  • 7.5.4. Chart - Global Market by Industry - Final Year
  • 7.5.5. Chart - Global Market by Industry - Share by Year
  • 7.5.6. Chart - Global Market by Industry - Segment Growth
• 7.6. Global Market Product - Overview
  • 7.6.1. Table - Global Market by Product
  • 7.6.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 7.6.3. Chart - Global Market by Product - Base Year
  • 7.6.4. Chart - Global Market by Product - Final Year
  • 7.6.5. Chart - Global Market by Product - Share by Year
  • 7.6.6. Chart - Global Market by Product - Segment Growth

8. Gene Editing Markets - By Application

• 8.1. Cell Line
  • 8.1.1. Table Cell Line - by Country
  • 8.1.2. Chart - Cell Line Growth
• 8.2. Plant
  • 8.2.1. Table Plant - by Country
  • 8.2.2. Chart - Plant Growth
• 8.3. Animal
  • 8.3.1. Table Animal - by Country
  • 8.3.2. Chart - Animal Growth
• 8.4. Celll Therapy
  • 8.4.1. Table Cell Therapy - by Country
  • 8.4.2. Chart - Cell Therapy Growth
• 8.5. Gene Therapy
  • 8.5.1. Table Gene Therapy - by Country
  • 8.5.2. Chart - Gene Therapy Growth
• 8.6. Diagnostics
  • 8.6.1. Table Diagnostics - by Country
  • 8.6.2. Chart - Diagnostics Growth
• 8.7. Research
  • 8.7.1. Table Research - by Country
  • 8.7.2. Chart - Research Growth
• 8.8. Other Application
  • 8.8.1. Table Other Application - by Country
  • 8.8.2. Chart - Other Application Growth

9. Global Gene Editing Markets - by Technology

• 9.1. Crispr
  • 9.1.1. Table Crispr - by Country
  • 9.1.2. Chart - Crispr Growth
• 9.2. Talens
  • 9.2.1. Table Talens - by Country
  • 9.2.2. Chart - Talens Growth
• 9.3. ZFN
  • 9.3.1. Table ZFN - by Country
  • 9.3.2. Chart - ZFN Growth
• 9.4. Meganuclease
  • 9.4.1. Table Meganuclease - by Country
  • 9.4.2. Chart - Meganuclease Growth
• 9.5. Other Technology
  • 9.5.1. Table Other Technology - by Country
  • 9.5.2. Chart - Other Technology Growth

10. Gene Editing Markets - by Place

• 10.1. In Vivo
  • 10.1.1. Table In Vivo - by Country
  • 10.1.2. Chart - In Vivo Growth
• 10.2. Ex Vivo
  • 10.2.1. Table Ex Vivo - by Country
  • 10.2.2. Chart - Ex Vivo Growth
• 10.3. In Vitro
  • 10.3.1. Table In Vitro - by Country
  • 10.3.2. Chart - In Vitro Growth

11. Gene Editing Markets - by Industry

• 11.1. Pharma
  • 11.1.1. Table Pharma - by Country
  • 11.1.2. Chart - Pharma Growth
• 11.2. Clinical
  • 11.2.1. Table Clinical - by Country
  • 11.2.2. Chart - Clinical Growth
• 11.3. Academic
  • 11.3.1. Table Academic - by Country
  • 11.3.2. Chart - Academic Growth
• 11.4. Contract
  • 11.4.1. Table Contract - by Country
  • 11.4.2. Chart - Contract Growth
• 11.5. Other Industry
  • 11.5.1. Table Other Industry - by Country
  • 11.5.2. Chart - Other Industry Growth

12. Global Gene Editing Markets - by Product

• 12.1. Instruments
  • 12.1.1. Table Instruments - by Country
  • 12.1.2. Chart - Instruments Growth
• 12.2. Cells
  • 12.2.1. Table Cells - by Country
  • 12.2.2. Chart - Cells Growth
• 12.3. Reagents
  • 12.3.1. Table Reagents - by Country
  • 12.3.2. Chart - Reagents Growth
• 12.4. Other Product
  • 12.4.1. Table Other Product - by Country
  • 12.4.2. Chart - Other Product Growth

13. Appendices

• 13.1. United States Medicare System: laboratory Fees Schedule
• 13.2. The Most Used IVD Assays
• 13.3. The Highest Grossing Assays
• 13.4. The Whole Genome Sequence of SARS-CoV-2
• 13.5. Global Listing of Sequencing Establishments - Location & Contacts

관련자료